In this episode of the Diagnosing Health Care Podcast: When analyzing the life cycle of any health care product, a key component to consider is how much the product will cost and who will pay for it.
What unique challenges do direct access tests (DATs) pose when it comes to reimbursement and related compliance requirements?
Blog Editors
Recent Updates
- Interested in Opening a Medical Spa? (Part II): Here’s (More) That You Need to Know
- Louisiana Becomes First State to Classify Mifepristone and Misoprostol as Controlled Substances
- California’s Office of Health Care Affordability Kicks into Action: Are Organizations Ready for Increased Scrutiny in Health Care Transactions?
- Nuts or Not Nuts? Second Circuit Declines to Consider Whether KIND’s Use of All-Natural Is Deceptive, Misleading
- HHS Publishes Final Rule to Support Reproductive Health Care Privacy